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Abstract
Background: The risk of schizophrenia is thought to be higher in population isolates that have recently been
exposed to major and accelerated cultural change, accompanied by ensuing socio-environmental stressors/
triggers, than in dominant, mainstream societies. We investigated the prevalence and phenomenology of
schizophrenia in 329 females and 253 males of a Southwestern American Indian tribe, and in 194 females and 137
males of a Plains American Indian tribe. These tribal groups were evaluated as part of a broader program of gene-
environment investigations of alcoholism and other psychiatric disorders.
Methods: Semi-structured psychiatric interviews were conducted to allow diagnoses utilizing standardized
psychiatric diagnostic criteria, and to limit cultural biases. Study participants were recruited from the community
on the basis of membership in pedigrees, and not by convenience. After independent raters evaluated the
interviews blindly, DSM-III-R diagnoses were assigned by a consensus of experts well-versed in the local cultures.
Results: Five of the 582 Southwestern American Indian respondents (prevalence = 8.6 per 1000), and one of the
331 interviewed Plains American Indians (prevalence = 3.02 per 1000) had a lifetime diagnosis of schizophrenia.
The lifetime prevalence rates of schizophrenia within these two distinct American Indian tribal groups is
consistent with lifetime expectancy rates reported for the general United States population and most isolate and
homogeneous populations for which prevalence rates of schizophrenia are available. While we were unable to
factor in the potential modifying effect that mortality rates of schizophrenia-suffering tribal members may have
had on the overall tribal rates, the incidence of schizophrenia among the living was well within the normative
range.
Conclusion:  The occurrence of schizophrenia among members of these two tribal population groups is
consistent with prevalence rates reported for population isolates and in the general population. Vulnerabilities to
early onset alcohol and drug use disorders do not lend convincing support to a diathesis-stressor model with
these stressors, commonly reported with these tribes. Nearly one-fifth of the respondents reported experiencing
psychotic-like symptoms, reaffirming the need to examine sociocultural factors actively before making positive
diagnoses of psychosis or schizophrenia.
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Background
Schizophrenia is a severe brain disease resulting in sub-
stantial loss of reproductive fitness in the past, but it is has
a lifetime prevalence close to 1% worldwide and across
cultures. It is clear that many individuals who are geneti-
cally vulnerable to schizophrenia do not express it, and
that schizophrenia is multifactorial, involving genes, envi-
ronmental factors, their interactions, and hypothesized
epigenetic factors. The evidence includes monozygotic
twin (MZ) concordances of about 50%, fraternal (DZ)
rates about 15%, high rates of schizophrenia in the off-
spring of the normal twin within discordant MZ pairs,
high rates in adoptees with a schizophrenic biological par-
ent and normal adoptive parents, as well as the rapid
decline of vulnerability to schizophrenia with decreasing
genetic relationship to a schizophrenic proband [1].
Strategies to understand the variable expression of vulner-
ability to schizophrenia – the gene/environment interac-
tion – include elucidation of the genetic risk factors, a
focus on endophenotypes or intermediate phenotypes
including premorbid cognitive differences shared by
schizophrenics and their unaffected relatives, and identi-
fication of environmental triggers including prenatal,
developmental and infectious agents. Cross-population
studies can evaluate the potential effects of multiple dif-
ferences between societies on prevalence or expression of
schizophrenia including sociocultural differences. The
risk of schizophrenia is thought to be higher in popula-
tions whose pre-existing cultural isolation has been
recently disturbed [2,3], and schizophrenia may be pre-
cipitated by these socio-environmental stressors [4,5].
Isolated populations provide an excellent setting to iden-
tify both genetic and environmental etiologies of schizo-
phrenia. The arguments for the use of isolates for genetic
etiology are well known. There are likely to be fewer, or,
increased susceptibility genes for a particular complex dis-
ease in genetic isolates as a result of the population having
passed through a "bottleneck". Genetic linkage and link-
age disequilibrium mapping methods are more readily
applied because of reductions in disease gene and marker
locus heterogeneity and better defined sampling frame-
works. For example, only one or two major ancestral Y-
haplotypes were found in South and Central American
Indian populations ([6] and in Finns [7] and genetic
diversity across a range of autosomally located short tan-
dem repeat loci [STRs] was reduced about 15% across
American Indian populations. These are findings indica-
tive of reduction in genetic diversity.
Reductions in environmental heterogeneity in isolates
and opportunities to observe effects of environmental fac-
tors- including cultural discontinuities – have sometimes
been less well appreciated. We were able to investigate the
prevalence and phenomenology of schizophrenia in a
Southwestern Indian tribe and a Plains Indian tribe –
which represent isolates in both the genetic and cultural
senses. Both populations evidence little genetic admixture
and virtually none to non-Indians. These populations
were evaluated as part of a broader gene-environment
investigation of alcoholism and other psychiatric disor-
ders. Ascertainment was unbiased by the schizophrenia
diagnosis or ascertainment for any disease. The diagnosis
of main focus for the study had been alcoholism, and the
prevalence of alcoholism as well as other social, demo-
graphic and genetic characteristics is very similar in these
family-ascertained population cross-sections to the source
tribal populations. Most critically for the purposes of this
study, both tribes have undergone accelerated change
within the past 200 years resulting in dramatic upsurges in
problems that were previously unknown to them (e.g.,
alcoholism, other substance dependencies, unemploy-
ment) or previously had been very different in magnitude
and expression (e.g., violence, trauma, within family
abuse). The prevalence and phenomenology of schizo-
phrenia in two distinct American Indian tribal popula-
tions is reported.
Methods
Study participants and sampling strategy
A total of 331 Plains (PL) and 582 Southwestern (SW)
American Indian adult participants were interviewed on
the basis of family membership. Tribal elders provided
information on multigenerational pedigrees. Three pedi-
grees for each tribe were selected on the basis of availabil-
ity of adult members, geographic accessibility, and
willingness of at least one family member to be an advo-
cate for the study. The family pedigrees coalesce, so it is
more accurate to regard each study population as a sub-
sample of the overall tribal pedigree.
Participants gave informed consent under a human
research protocol approved by the Institutional Review
Board of the National Institute on Alcoholism and Alco-
hol Abuse, National Institutes of Health, and the respec-
tive tribal councils, and was conducted in compliance
with the Helsinki Declaration. Focus groups comprised of
tribal staff and community members reviewed testing
instruments and procedures for participant recruitment
and data collection. Community support was critical in
attaining a high level of study participation. Employing
members of the community for recruitment and portions
of the data collection facilitated rapport with participants.
Completion rates were noteworthy, yielding 98% of the
PL and 94% of the SW eligible persons contacted.
Participants were 21 years of age or older and eligible for
official enrollment in the SW and PL tribes (requiring ≥ 1/
4th tribal blood). These populations were chosen forBMC Psychiatry 2007, 7:30 http://www.biomedcentral.com/1471-244X/7/30
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genetic transmission and linkage studies on alcoholism
and psychiatric disorders. Due to the high prevalence of
alcoholism in this population, there was no need to ascer-
tain through an alcoholic proband. Pedigrees were
selected on the basis of structure and accessibility only
and without knowledge or reference to their clinical histo-
ries or to the clinical histories of relatives. Thus, there was
no initial diagnostic bias. Also, pedigrees were exhaus-
tively analyzed and data were obtained on nearly all
members of the families including those on and off-reser-
vation. Participants represented approximately 10% of
the adult members of the SW tribe and 12% of the adult
members of the PL tribe.
We used genealogical information to address the extent to
which the family-derived samples were genetically repre-
sentative. For the SW tribe, the fraction of genes shared by
common descent was calculated for 169,071 pairs of par-
ticipants. A randomly drawn pair of individuals shared
1.2% of their genes by descent, indicating that most pairs
have a low degree of relationship. The average degree of
relationship for the whole tribe has not been measured
but the average sharing by descent of 1.2% is compatible
with the tribal population's size and history. Preliminary
analyses for the PL tribe by Bernard Albaugh in a manu-
script under preparation indicate a similar average degree
of genetic relationship.
Detailed genetic, demographic, and social data allowed
comparison of the representativeness of the samples to
the overall populations of the two tribes as could be eval-
uated using US Census data. The data indicate representa-
tive samples, except for some definitional variations such
as incorporating common-law relationships of > 1 year
into the "marriage" category [8].
Comparative rates of schizophrenia in this study's two
American Indian tribal groups, in other isolate popula-
tions, and in homogeneous populations were analyzed
using 95% Confidence Intervals and Standard Error meas-
ures.
Interviews and psychiatric diagnoses
Interviews were conducted with a modified version of the
Schedule for Affective Disorders and Schizophrenia-Life-
time version (SADS-L) [9]. Probes were added to allow
diagnoses utilizing both Research Diagnostic [10] and
Diagnostic and Statistical Manual of Mental Disorders,
Third Edition-Revised (DSM-III-R) criteria [11], and to
limit cultural biases. The SADS-L has well-established
validity in population and clinical studies [12] and is reli-
able when administered to American Indians by clinicians
experienced with psychiatric assessment in these popula-
tions [13-16]. Diagnoses were sometimes augmented by
collateral information from educational, court, and med-
ical records and in collaboration with family members. In
several cases, additional information was obtained when
participants showed evidence of a current psychotic epi-
sode or where memory impairment was evident.
A psychologist and a clinical social worker with a com-
bined total of 40 years experience in psychiatric assess-
ment in diverse American Indian populations
administered the SADS-L interviews. Clinical interviews
were rated blindly for DSM-III-R lifetime and point prev-
alence diagnoses yielding good to excellent rates of agree-
ment between two independent blind raters (kappa
coefficients ranged from 0.63 to 1.00). Diagnostic differ-
ences were resolved in a consensus conference that
included a senior psychiatrist experienced in the psychiat-
ric assessment of American Indians. Provisions were made
to limit diagnostic errors due to culture-specific phenom-
ena. For example, visual and auditory hallucinations that
occurred within the context of American Indian ceremo-
nies and rituals were not considered to be indicative of
psychosis or schizophrenia [17,18].
Frequency of response to six symptoms for psychosis was
calculated for each tribe. The six symptoms were: (1)
heard voices that could not be heard by other people, (2)
had visions or saw things that were not visible to other
people, (3) had strange bodily feelings, (4) had beliefs
later found out not to be true, (5) did something to call
attention to oneself, and (6) people had difficulty under-
standing what subject was saying because of mixed up
speech and lack of sense. Positive responses that were
attributed to withdrawal symptoms or alcohol psychosis
were coded in the negative. Probes and additional ques-
tions (e.g., delusions, formal thought disorder, duration,
number of episodes) were added. Due to incomplete
responses, four (4) SW and 69 PL individuals were com-
pletely eliminated from the analyses. Another 18 individ-
uals did not respond to at least one of the six
schizophrenic symptoms, further reducing the N for anal-
ysis of the individual symptom items.
Results
We investigated the prevalence and phenomenology of
DSM-III-R schizophrenia in 329 females and 253 males
from a SW tribe, and in 194 females and 137 males of a
PL tribe [Table 1]. As described in Methods, the two tribal
samples were representative in terms of degree of relation-
ship and demographic features, and, as described else-
where, they were similar in distribution for gender, age,
and education (Robin et al., 1999).
Of the 582 SW Indian respondents, five (4 M, 1 F) were
diagnosed with schizophrenia (Prevalence = 8.6 per
1000). Prevalence was 3.02 per 1000 in the PL Indians (1/
331, 1 M). Two SW Indians were in a current episode atBMC Psychiatry 2007, 7:30 http://www.biomedcentral.com/1471-244X/7/30
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the time of interview. Age of onset for schizophrenia was
14,15, 17,19, and 26 for the five SW Indians, and age of
onset was 22 for the one PL Indian. All five SW schizo-
phrenics reported psychotic symptoms, and four of them
had four or more positive responses out of six possible.
The PL schizophrenic had five positive responses.
Each SW Indian schizophrenic had at least two other life-
time psychiatric disorders. These included alcohol
dependence or abuse (5/5), drug use disorder (5/5), and
antisocial personality disorder (3/5). The abused drugs
were cannabis (4/5) and inhalants (4/5). One schizo-
phrenic reported hallucinogen abuse. In every case, onset
of schizophrenia was preceded by either alcohol (mean
age = 14) or drug abuse (mean age = 11). The PL schizo-
phrenic had agoraphobia but no indication of a substance
abuse disorder.
Many of the non-schizophrenic SW (N = 573) and PL (N
= 261) Indians also had one or more symptoms of schiz-
ophrenia. 21% (120/573) of the non-schizophrenic SW
Indians responded positively to at least one of the initial
six standardized questions for psychosis, and 12% (67/
573) responded positively to two or more questions.
Auditory and visual hallucinations were reported by 15%
(86/573) of the non-schizophrenic participants and
reported together 84% (72/86) of the time. The other four
symptoms (strange feelings in body, false beliefs or ideas,
calling attention to oneself with strange behavior, speech
difficult to understand) were reported by 2% to 5% of SW
Indians.
Approximately 17% (44/261) of the non-schizophrenic
PL Indians had at least one psychotic symptom, and 10%
(27/261) responded positively to two or more symptoms.
Auditory and visual hallucinations were reported by 10%
of the participants and co-occurred 93% of the time. The
other four psychotic symptoms were reported by 1% to
4% of PL respondents.
None of the five affected SW Indians were first-degree rel-
atives. However, there were some common elements in
their social backgrounds. Four of the five SW schizophren-
ics had been removed from their homes as children and
placed into foster care or missionary school as compared
to 13% of the non-schizophrenics. Three of the four ques-
tioned about childhood sexual abuse reported being sex-
ually abused prior to the age of sixteen. Four had been
arrested and jailed. Their educational levels varied. Two
dropped out of school after the 5th and 9th grades, and the
other three graduated from high school. The PL Indian
with schizophrenia had no reported history of childhood
problems and completed high school.
Discussion
Worldwide studies on the prevalence of schizophrenia
[Table 1] suggest considerable variation [19,20]. As can be
seen, the studies include homogenous and isolate popula-
tions from Micronesia, Ethiopia, Ireland, arctic Canada,
and American Indian tribal groups, as well as cosmopoli-
tan populations. Comparative rates of schizophrenia in
these populations range from 2.4 per 1000 [21] to 29.58
per 1000 [22].
Data on the prevalence of schizophrenia in American
Indians is mixed. A lifetime prevalence rate of schizophre-
nia of 22.7 per 1000 was identified among Indians from
Saskatchewan, contrasting with a rate of 2.4 per 1000 for
non-Indians living in the same region [22], but not really
different from rates of about 1-3% found in other popula-
tions worldwide. The lifetime rate of schizophrenia was
3% for a Northwestern Indian tribe [23] and 8% for a Baf-
fin Eskimo settlement [24].
In all of these studies, sample sizes were small or modest,
and with only a few exceptions, no standardized psychiat-
ric interviews with well-defined criteria for schizophrenia
were used. In previous studies of North American Indians,
it's likely that the prevalence of schizophrenia was "over-
estimated in early clinical and epidemiological studies
because of the tendency for North American psychiatrists
to misdiagnose bipolar affective disorder as schizophre-
nia" [25]. A failure to use standardized instruments and
criteria can result in a misdiagnosis of an individual's dis-
Table 1: Comparative rates of schizophrenia in isolate and homogenous populations
Southwest 
Indians
Plains 
Indians
Roy, et al1 
[56]
Sampath, et 
al2 [57]
Kinzie, 
et al3 
[58]
Kebede, 
et al4 
[59]
Myles-
Worsley, et 
al5 [60]
Scully, et al6 
[62]
McConnell, 
et al7 [61]
Bates, Van 
Dam8 [64]
National 
Comorbidity 
Study9 [63]
N 582 331 1218 214 131 68,378 13,750 29,542 1242 12,200 8098
Prevalence per 1000 8.6 3.02 22.17 29.58 21.00 4.69 11.64 3.89 2.42 3.1 5.00
95% C.I. ± 2.4 ± 1.1 ± 2.6 ± 2.8 ± 2.5 ± 1.2 ± 2.0 ± 1.2 ± 0.9 ± 1.2 ± 1.4
S.E. 0.012 0.006 0.013 0.014 0.013 0.006 0.01 0.006 0.005 0.0005 0.007
11970, Saskatchewan Reservation, age 15+; 21974, Baffin Island Eskimo, age 15+; 31988, Western United States Native Americans, age 20+; 42003, Butajira-Ethiopia, age 15-49; 
51999, Palau, Micronesia, age 15+; 62004, Co. Monaghan, Ireland, age 0+; 72002, District of Derry, Ireland, age 18-64; 81984, British Columbia Coastal Indians; 9 1994, United 
States population-based, age 15-54BMC Psychiatry 2007, 7:30 http://www.biomedcentral.com/1471-244X/7/30
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turbed or psychotic-like behavior whether drug-induced,
catalyzed by depression, or indicative of another psychiat-
ric condition [26].
A common problem in cross-population studies is diag-
nostic variation [27]. Reported findings of schizophrenia
among American Indians have also been hampered by
their reliance on small clinical samples and a failure to
adequately consider the role of substance abuse in lending
expression to psychotic symptoms [28-31]. A further lim-
itation concerns the accuracy and validity of diagnoses for
schizophrenia and other psychotic disorders, often
thought to have been made with little or no awareness of
culturally bound syndromes specific to American Indian
societies [32]. Nevertheless, only Sampath's 1974 study
demonstrated substantial lifetime prevalence rates above
the norm.
The occurrence of schizophrenia within these two distinct
American Indian tribal groups is consistent with the 0.3-
2.8% [33] and 1.3% [34] life-time expectancy rates
reported for the general United States population and
below the approximate 2.5% risk reported for second-
degree relatives [4,35]. While we were unable to factor in
the potential modifying effect that mortality rates of schiz-
ophrenic tribal members may have had on the overall
tribal rates, the incidence of schizophrenia among the liv-
ing was well within the normative range.
The fact that schizophrenia prevalence rates for these two
American Indian populations groups do not appear to be
different from most other population groups is striking
considering the degree by which they have undergone cul-
tural change and are rife with stress. These stressors have
been exacerbated by the SW and PL tribal groups' expo-
sure to accelerated and dramatic lifestyle changes resulting
in poverty and low socioeconomic conditions [36], out-
of-home placements [37], and for the SW tribal group, fre-
quent exposure to lifetime traumatic events including
child sexual abuse [38,39]. Nevertheless, these tribal
groups' rates of schizophrenia remain consistent with
those found in most other populations despite the pres-
ence of significant stressors hypothesized – within the
context of the diathesis-stressor model – to catalyze the
expression of schizophrenia.
None of the diagnosed schizophrenic study participants
were closely related to each other, but as might be
expected from the inheritance of schizophrenia, were
more related than average. On the other hand, no one
genetic cluster is represented, none are siblings, and two
of the five are unrelated to any of the others [Table 2].
Interviews with their first-degree relatives revealed no pre-
vious history of family schizophrenia, though our study
sample was limited in that not all family members were
interviewed and histories of schizophrenia did not extend
beyond three generations. Nevertheless, extensive super
pedigrees were sampled with the study findings lending
support to the likely etiologic heterogeneity of schizo-
phrenia in these two tribal populations [40]. However,
the fact that many of the study participants were part of
"superfamilies" can cause some noise in the calculation of
prevalences.
Specific vulnerabilities lending support to a diathesis-
stressor model were in evidence, however, life stressors are
common among American Indian societies. Most striking
is that neither tribe had a high prevalence of schizophre-
nia despite reported stressful socioeconomic conditions
and high prevalence rates of alcohol and drug use disor-
ders. Substance abuse disorders preceded the onset of
schizophrenia in all but one of the six diagnosed schizo-
phrenics, a common finding in studies of inpatient schiz-
ophrenic populations [41-43]. Cannabis abuse in
particular has been found in clinical and epidemiological
studies to exacerbate the symptoms of schizophrenia with
indications that it may precipitate schizophrenia [44,45].
Similar findings have been reported for inhalant abuse
when comparing schizophrenic groups, both with other
psychiatric patient groups and normal subjects [46-49].
Yet despite high rates of alcohol and other drug use disor-
ders in the two American Indian tribal groups under
study, the prevalence rates of schizophrenia were not ele-
vated. Other commonly identified stressors included
child sexual abuse and out-of-home placement. Exposure
of populations with psychosis and schizophrenia to child
physical and sexual abuse has seldom been investigated,
but the few inpatient studies available report significant
associations between these conditions [50-52].
Nearly 20% of a combined 840 tribal study participants
responded positively to questions about psychotic symp-
toms that were not related to the use of substances such as
alcohol. This percentage is similar to findings of delu-
sions, paranoid thoughts, and other psychotic symptoms
reported to occur in the general population [53-55],
though the underlying manifestations for the expression
of psychotic symptoms may differ for American Indian
people. Reported symptoms for the two American Indian
groups under study were most often described within a
traditional cultural and spiritual context. For example, in
these tribal groups a common symptom of bereavement is
seeing or hearing the deceased person at which time pre-
scribed ways are invoked to provide relief to the bereaved.
Another commonly reported experience is participation
in traditional ceremonies such as the Sundance and sweat
lodges. These events intentionally alter the participant's
physical, emotional, and spiritual status in which visions
and paranormal experiences are expected to occur. VisionBMC Psychiatry 2007, 7:30 http://www.biomedcentral.com/1471-244X/7/30
Page 6 of 8
(page number not for citation purposes)
Quests are another activity that can alter one's conscious-
ness. In this instance, the individual travels to a remote
sacred location, abstains from food and water for several
days with limited or no personal contact. The expectation
in these circumstances is to gain perspective and knowl-
edge by experiencing visions.
The occurrence of psychotic symptoms in non-schizo-
phrenics demonstrates that the diagnosis for schizophre-
nia is not to be made by finding evidence of a few
psychotic symptoms, but by meeting a sufficient group of
finite criteria. In the case of these two American Indian
tribal groups, the phenomenology of schizophrenia
appears classic – the non-familiality is consistent with the
multifactorial-polygenic nature of schizophrenia and the
comorbid diagnoses are consistent as well. While it
remains an open-ended question whether schizophrenia
is more common in certain populations, shedding evi-
dence on etiology is the best evidence. Our findings dem-
onstrate that when schizophrenia is carefully measured, it
has been found to be neither especially abundant nor rare
in American Indian tribal groups despite the fact they have
factors that have been asserted to be etiologic or trigger-
ing.
Conclusion
In sum, it appears that the occurrence of schizophrenia
among members of these two tribal population groups is
consistent with prevalence rates reported for most popu-
lation isolates and in the general population. While the
number of diagnosed schizophrenics was too small to
subject to refined statistical analysis, we found similarly
reported associations with substance abuse and child-
hood deprivation and abuse. Finally, nearly one-fifth of
the respondents reported experiencing psychotic-like
symptoms. At least in these two tribal groups, the number
of positive responses to what are intended to be indices of
psychotic behavior reaffirms the need to consider socio-
cultural factors actively before making positive diagnoses
of psychosis or schizophrenia.
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